Oculis Holding AG Warrants (OCSAW)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Oculis Holding AG Warrants (OCSAW) is down 47.6% since the beginning of the year. At $4 per share, OCSAW is trading 80.2% below its 52-week high of $23.

Oculis Holding AG Warrants (OCSAW) has returned -47.55% so far this year and -47.33% over the past 12 months.

Based on dividend-adjusted daily data since Mar 3, 2023, OCSAW's average daily return is +0.61%, while the average monthly return is +12.84%. At this rate, an investment would double in approximately 0.5 years.

Historically, 55% of months were positive and 45% were negative. The best month was Oct 2024 with a return of +161.9%, while the worst month was Jun 2026 at -63.4%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 3 months.

On a daily basis, OCSAW closed higher 28% of trading days. The best single day was Jan 4, 2024 with a return of +60.5%, while the worst single day was Jan 3, 2024 at -49.3%.

Oculis Holding AG Warrants has an annualized alpha of 292.07%, beta of 0.80, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since March 03, 2023.

• This stock captured 494.50% of S&P 500 Index gains and 184.33% of its losses - amplifying both gains and losses, but participating more in upside than downside.
• R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

OCSAW ranks 23 for risk / return — below 23% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Oculis Holding AG Warrants. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Oculis Holding AG Warrants was 82.96%, occurring on Jun 8, 2026. The portfolio has not yet recovered.

The current Oculis Holding AG Warrants drawdown is 79.87%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Oculis Holding AG Warrants over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Oculis Holding AG Warrants is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.